How we got here
From launching in June 2020 to our planned open consultation in July 2021, GCTC's journey is detailed below..
The GCTC launched to produce reliable and proportionate Guidance for RCTs in all health interventions.
Jan - Mar 2021
Guidance development of the first draft. Quicksand, a design-thinking and innovation practice based in India, began consultations with RCT teams and participants in India, South Africa, Nigeria, Thailand, Brazil, Sierra Leone and Kenya to gather insights from diverse RCT types and settings.
Final draft published for open consultation
October - November 2021
Finalising the final version of the guidance.
June -July 2020
We ran a global survey to hear from researchers whose trials had been impacted by the Covid-19 pandemic to capture the innovative practices that have enabled some trials to continue and the challenges that have affected others.
Further consultation with multidisciplinary stakeholders and programme of participant/public focused workshops.
Produced the report on Conducting Clinical Trials During a Pandemic: Reviewing the resilience of the ecosystem for Randomized Controlled Trials (RCTs). This report was based on the global survey of researchers experiences, we ran in 2020.
Sep -Dec 2020
We consulted our Steering Group and over 80 experts through a series of workshops focusing on the writing process and Guidance document content.
May -June 2021
Guidance development of the second draft. Quicksand completed its consultations and produced a report with findings and recommendations for the guidance.
August - September 2021
The public consultation on the draft guidance where we received global feedback to help shape the guidance and ensure that it is applicable in all settings.
Translation of draft guidance into Arabic, simplified Chinese, Japanese, Spanish, French
Website visits from over 120 countries
30th September, close of formal consultation